$SEIC Cashflow Statement | Understand Stock

$SEIC

$103.20 +$0.32 (0.31%) Close

$SEIC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
Amortization
Equity in earnings of unconsolidated affiliates
Partner distributions received from unconsolidated affiliate
Stock-based compensation
Provision for losses on receivables
Deferred income tax benefit
Net (gain) loss from investments
Net gain from business divestiture
Net gain from sale of property
Change in other long-term liabilities
Change in other assets
Contract costs capitalized, net of amortization
Contingent consideration fair value adjustment
Write off of fixed assets and capitalized software
Insurance rebates received for Health and Welfare Benefit Plan Trust
Insurance rebates transferred to Health and Welfare Benefit Plan Trust
Other
Change in current assets and liabilities:
Receivables from investment products
Receivables
Other current assets
Advances due from unconsolidated affiliate
Accounts payable
Accrued liabilities
Deferred revenue
Consolidated variable interest entities related:
Change from investment security transactions
Net gain from investments
Consolidated VIEs
Total net gain from investments
Change in other assets and liabilities
Total adjustments
Net cash provided by operating activities
Cash flows from investing activities:
Additions to property and equipment
Additions to capitalized software
Purchases of marketable securities
Purchases of interest in limited partnerships
Prepayments and maturities of marketable securities
Sales of marketable securities
Proceeds from fixed asset dispositions
Proceeds from business divestiture
Cash paid for acquisitions, net of cash acquired
Proceeds from insurance settlements
Advance payment for acquisition
Other investing activities
Net cash used in investing activities
Cash flows from financing activities:
Payments under revolving credit facility
Borrowings under revolving credit facility
Payment of contingent consideration
Purchase and retirement of common stock
Proceeds from issuance of common stock
Payment of dividends
Non-controlling interest capital raised
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents and cash and cash equivalents held at consolidated variable interest entities
Cash and cash equivalents and cash and cash equivalents held at consolidated variable interest entities, beginning of year
Consolidated VIEs
Total cash and cash equivalents and cash and cash equivalents held at consolidated variable interest entities, beginning of year
Cash and cash equivalents and cash and cash equivalents held at consolidated variable interest entities, end of year
Consolidated VIEs
Total cash and cash equivalents and cash and cash equivalents held at consolidated variable interest entities, end of year
Interest paid
Operating lease right-of-use assets and net lease liabilities recorded upon adoption of ASC 842
Income taxes paid
Non-cash investing and financing activities:
Acquisition of businesses in current assets, property and equipment, current liabilities and other long-term liabilities
Dividends declared but not paid

Comments